Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections

Intramyometrial and Intravenous Oxytocin Compared to Intravenous Carbetocin for Prevention of Postpartum Hemorrhage in Elective Cesarean Sections - a Monocentric Randomized Controlled Study

Objective is to proof non-inferiority of intramyometrial and intravenous oxytocin application compared to intravenous carbetocin for prevention of postpartum hemorrhage in planned, uncomplicated cesarean deliveries.

Inclusion Criteria:

• elective cesarean section
• present informed consent
• completed 36 weeks of gestation

Exclusion Criteria:

• need for intubation (carbetocin is only licensed for epidural or spinal anesthesia)
• multiple fetus pregnancy
• known coagulopathy
• Placenta praevia
• morbidly adherent placenta
• placental abruption
• thrombocyte dysfunction
• HELLP-syndrome
• preeclampsia
• history of uterine atony